IDRx, Inc. raised $120 million in a Series B financing led by RA Capital Management to advance the development of its lead product candidate IDRX-42 for gastrointestinal stromal tumors.
Amount Raised
$120 Million
Round Type
Series B
PlymouthBiotechnologyHealth CareTherapeuticsPharmaceuticalInvestors
Description
IDRx has completed an oversubscribed $120 million Series B Preferred Stock financing to support its ongoing clinical studies. The financing was led by RA Capital Management and includes participation from several strategic investors to further the development of IDRX-42.
Quick answer
IDRx raised $120 Million in a Series B round, dated August 7, 2024. Investors: Nextech Invest, Ltd, Merck K Ga A, Forge Life Science Partners, Casdin Capital, Andreessen Horowitz, Rock Springs Capital, Blackstone Multi Asset Investing and Commodore Capital. IDRx is based in Plymouth, Massachusetts, United States.
- How much did IDRx raise?
- IDRx raised $120 Million in a Series B round on August 7, 2024.
- Who invested in IDRx?
- Nextech Invest, Ltd, Merck K Ga A, Forge Life Science Partners, Casdin Capital, Andreessen Horowitz, Rock Springs Capital, Blackstone Multi Asset Investing and Commodore Capital are named as investors in this round.
- What does IDRx do?
- IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies.
- Where is IDRx based and how big is it?
- IDRx is based in Plymouth, Massachusetts, United States. Fundz records about 45 employees.
- Who are the decision-makers at IDRx?
- Fundz holds 1 contact at IDRx. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as IDRx that raised within 45 days of this round, from Fundz verified event records.
- Cumulus Oncology raised $50M (Series A) on September 3, 2024.
- Pathalys Pharma raised $105M (Series B) on August 21, 2024.
- Retension Pharmaceuticals raised $10M (Series A) on August 21, 2024.
- Lipella Pharmaceuticals raised $120K on July 31, 2024.
- Amporin Pharmaceuticals raised $170K (Grant) on July 26, 2024.
- Pelthos Therapeutics raised $750K on July 24, 2024.
Who to call at IDRx, and when
A new round usually means IDRx is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day IDRx raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at IDRx, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at IDRx. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment IDRx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansIDRx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.